Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant

被引:0
|
作者
Grace Chen
Ronald Lee
Astrid-Maria Højer
Jeppe Klint Buchbjerg
Michael Serenko
Zhen Zhao
机构
[1] Takeda Development Center Americas,Clinical Pharmacology
[2] H. Lundbeck A/S,Pharmacovigilance
[3] Takeda Development Center Americas,Statistics
[4] Takeda Development Center Americas,undefined
来源
关键词
Omeprazole; Fluconazole; Ketoconazole; Bupropion; Major Depressive Disorder Patient;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:727 / 736
页数:9
相关论文
共 50 条
  • [1] Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
    Chen, Grace
    Lee, Ronald
    Hojer, Astrid-Maria
    Buchbjerg, Jeppe Klint
    Serenko, Michael
    Zhao, Zhen
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 727 - 736
  • [2] Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
    Mork, Arne
    Montezinho, Liliana P.
    Miller, Silke
    Trippodi-Murphy, Crista
    Plath, Niels
    Li, Yan
    Gulinello, Maria
    Sanchez, Connie
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 105 : 41 - 50
  • [3] Lu AA21004, A Novel Multimodal Antidepressant
    Sanchez, Connie
    NEUROTHERAPEUTICS, 2012, 9 (03) : 681 - 682
  • [4] In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets
    Westrich, Ligia
    Pehrson, Alan
    Zhong, Huailing
    Nielsen, Soren Moller
    Frederiksen, Kristen
    Stensbol, Tine Bryan
    Boyle, Noel
    Hentzer, Morten
    Sanchez, Connie
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2012, 16 : 47 - 47
  • [5] Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice
    Guilloux, Jean-Philippe
    Mendez-David, Indira
    Pehrson, Alan
    Guiard, Bruno P.
    Reperant, Christelle
    Orvoen, Sophie
    Gardier, Alain M.
    Hen, Rene
    Ebert, Bjarke
    Miller, Silke
    Sanchez, Connie
    David, Denis J.
    NEUROPHARMACOLOGY, 2013, 73 : 147 - 159
  • [6] Preclinical effects of Lu AA21004, a novel multimodal antidepressant
    Mork, A.
    Pehrson, A.
    Montezinho, L. C.
    Karlsson, J. J.
    Murphy, C. Trippodi
    Miller, S.
    Fischer, C. W.
    Liebenberg, N.
    Wegener, G.
    Sanchez, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S268 - S269
  • [7] Vortioxetine ( Lu AA21004), a multimodal antidepressant: differentiation from current antidepressants in animal models of depression
    Mork, A.
    Pehrson, A. L.
    Betry, C.
    David, D.
    Li, Y.
    Gulinello, M.
    Leiser, S. C.
    Haddjeri, N.
    Sanchez, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S392 - S393
  • [8] A population pharmacokinetic meta-analysis of vortioxetine (Lu AA21004) in healthy subjects
    Areberg, Johan
    Chen, Grace
    Naik, Himanshu
    Pedersen, Kamilla B.
    Vakilynejad, Mayid
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2012, 16 : 15 - 15
  • [9] Vortioxetine (Lu Aa21004), An Investigational Multimodal Antidepressant: Differentiation from Currently Used Antidepressants in Preclinical Rodent Models
    Sanchez, Connie
    Pehrson, Alan L.
    Betry, Cecille
    David, Denis
    Li, Yan
    Gulinello, Maria
    Leiser, Steve C.
    Haddjeri, Nasser
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 106S - 107S
  • [10] Impact of the Multimodal Antidepressant Lu AA21004 on Serotonin Transmission in the Rat Hippocampus
    Lecours, Maurice
    El Mansari, Mostafa
    Blier, Pierre
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 301S - 301S